More on SYRE

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-406.7% Growth)
- Ratings (9.3 Score)

Upcoming Events

- Earnings (11/5/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Spyre Therapeutics (NQ:SYRE)
Delayed: 88.50 -0.83 (0.93%)
Prev. Close $89.33  
Open$87.06 
52 Wk High$ 
52 Wk Low$ 
Day High$90.00 
Day Low$85.00 
P/E N/A  
EPS$ 
Volume1,429,115 

Friends, Peers and Foes (?): ABVX, ORKA, INTU, NCNO, SMTC (more...)

Aug 27, 2026 06:19 AM Spyre (SYRE) PT Lowered to $116 at Baird
Aug 27, 2026 02:20 AM Guggenheim Reiterates Buy Rating on Spyre (SYRE)
Aug 26, 2026 07:28 AM Spyre (SYRE) Reiterated at Buy by Stifel on Topline Results From RA PoC Sub-Study
Aug 25, 2026 04:41 PM After-Hours Movers: INTU, SMTC, SYRE, ZM, NCNO
Aug 25, 2026 04:05 PM Form 8-K Spyre Therapeutics, Inc. For: Aug 25
Aug 25, 2026 04:01 PM Spyre RA drug trial misses internal bar despite some efficacy
Aug 25, 2026 04:01 PM Spyre Therapeutics Announces Topline Results from the Rheumatoid Arthritis Sub-study of the SKYWAY Phase 2 Trial of SPY072
Aug 14, 2026 05:24 PM Form SCHEDULE 13G/A Spyre Therapeutics, Inc. Filed by: PERCEPTIVE ADVISORS LLC
Aug 14, 2026 08:10 AM Form SCHEDULE 13G/A Spyre Therapeutics, Inc. Filed by: RTW INVESTMENTS, LP
Aug 12, 2026 09:45 AM Spyre (SYRE) PT Raised to $140 at Jones Trading
View All Articles

Entities mentioned with syre

View All Entities